Login / Signup

Risedronate use may blunt appendicular lean mass loss secondary to sleeve gastrectomy: Results from a pilot randomized controlled trial.

Laura E FloresKristen M BeaversDaniel P BeaversKatelyn A GreeneDiana A MadridRyan M MillerJamy D ArdLaura D BilekAshley A Weaver
Published in: JCSM rapid communications (2022)
Pilot data indicate risedronate treatment may mitigate appendicular lean mass loss following SG. Further study is warranted.
Keyphrases
  • randomized controlled trial
  • study protocol
  • bone mineral density
  • electronic health record
  • big data
  • postmenopausal women
  • systematic review
  • body composition
  • machine learning
  • data analysis